Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rang in aandelen #41417
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2025-06-11
Marktkapitalisatie
$21.52K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Categorie

Aandelsplitsingen voor Diagnocure, Inc. (DGCRF)
Het aandeel Diagnocure, Inc. (symbool: DGCRF) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 13, 2026.
Eén aandeel DGCRF dat vóór Aug 13, 2026 werd gekocht, staat nu gelijk aan 0 aandelen DGCRF.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
2 x4
IE
0 -
CN
0 -
CH
0 -
CH
0 -
CN